| |
|
Key Position
Statements
Public Policy
Library
AST
Employee Leave &
Organ Donation Program
AST
Newsletter Articles
AST Homepage
WASHINGTON
REPRESENTATIVE:
Bill Applegate
Director of
Government Relations
Armstrong Teasdale LLP
1747 Pennsylvania Avenue, NW
Suite 300
Washington, DC 20006-4604
P: 202- 454-2864
F: 202- 393-0363
wapplegate@armstrongteasdale.com
American Society
of Transplantation
15000 Commerce Pkwy.
Mt. Laurel, NJ 08054
P: 856-439-9986
F: 856-439-9982
ast@ahint.com
|
| |
AST
NEWSLETTER: PUBLIC POLICY ARTICLES |
| |
|
| Below
are Public Policy articles that appeared in AST 2003 through
2006 Newsletters. For articles prior to 2003, go to the
Publications section of the AST
homepage for archived issues of the AST Newsletter. |
|
| January/February
2006 |
| • |
AST Makes Progress
During the 1st Session of the 109th Congress and Prepares
for 2006 |
| November/December
2005 |
| • |
Congressional Letter
from Congressmen Dave Camp (R-MI) and Ted Strickland (D-OH)
to the U.S. House of Representatives Regarding H.R. 2051 |
| September/October
2005 |
| • |
AST Public Policy
Committee Advances Agenda and Mobilizes Congressional
Leaders |
| July/August
2005 |
| • |
July 12, 2005 letter
to the U.S. General Accountability Office (GAO) |
| May/June
2005 |
| • |
AST
Government Relations Spends Much of the Spring on Capitol
Hill |
| • |
Dr.
Bumgardner Testifies Before House on Federal Funding for
Transplantation |
| • |
AST
Provides First “Transplant 101” Educational
Briefing on Capitol Hill before the Congressional Kidney
Caucus |
| • |
AST
Public Policy Committee Fly in to Brief Members of Congress
and Advocate Full Funding of New Organ Donation Law |
| March/April
2005 |
| • |
AST
Welcomes New Congress to Capitol Hill |
| • |
Public
Policy Committee Flies into Capitol Hill |
| • |
AST
Works with Key National Transplant Stakeholder Organizations
to Fund Organ Donor Law |
| • |
New
Secretary Takes Helm at Department of Health and Human
Services (HHS) |
| January/February
2005 |
| • |
AST
Public Policy Committee on Capitol Hill in Preparation
for New Congress |
| • |
HHS
Secretary Tommy Thompson Resigns, President Bush Nominates
Former Governor of Utah |
| November/December
2004 |
| • |
National
Elections Change Political Landscape: Transplantation
Champion Elected to Senate Leadership Post |
| September/October
2004 |
| • |
Educating,
Cultivating, and Mobilizing Congressional Support During
the Summer Months |
| July/August
2004 |
| • |
Disparities
in Health Care - AST Meets with Congressional Leaders
and Administration Officials to Address Critical Problem |
| • |
Access
to Transplantation - AST Responds to New Inquiries |
| • |
HHS
Re-examines the Issue of Obesity - AST Continues to Support
Key Initiatives to Combat Obesity |
| May/June
2004 |
| • |
AST
Seeks Full Funding for New Organ Donation and Recovery
Improvement Law |
| • |
AST
Convenes First-Ever National Conference on the "Economics
of Transplantation" |
| • |
AST
Attends Senate Republican Conference's Minority Health
Quality Forum |
| March/April
2004 |
| • |
Society
Provides Expertise to the Office of the HHS Secretary
and Broader Department Officials on Issue of Generic
Drugs and Immunosuppression |
| • |
Public
Policy Committee Meets on Capitol Hill to Kick-Off the
Second Session of the 108th Congress |
| • |
AST
Works with Congressional Leaders to Introduce Health Disparity
Legislation - "Closing the Health Care Gap Act"
|
| • |
Society
Continues to Keep Pressure on Congress to Pass "Organ
Donation and Recovery Improvement Act" |
| January/February
2004 |
| • |
AST
Public Policy Committee Travels to Capitol Hill As the
Senate Completes Action on Organ Donation Legislation |
| • |
AST
Advocacy for NIH |
| • |
AST
to Examine the Economics of Organ Transplantation |
| November/December
2003 |
| • |
US
Senate Passes Organ Donation Legislation |
| September/October
2003 |
| • |
Congress
and the Institutes of Medicine Examine NIH |
| • |
AST
Plays Role in Working With Congress to Strengthen NIH |
| July/August
2003 |
| • |
No
Summer Break for the AST Public Policy Committee |
| • |
AST
Testifies Before the Institutes of Medicine on Pediatric
Research |
| May/June
2003 |
| • |
AST
on Capitol Hill for Medicare Prescription Drug Debate |
| • |
AST
to Testify on Pediatric Issues at the Institute of Medicine |
| March/April
2003 |
| • |
Secretary
of HHS and Senate Majority Leader Join AST for the Society’s
2nd Congressional Transplantation Public Policy Awards |
| • |
AST
Unveils “Position Statements & Key Messages”
at the Society’s Capitol Hill Reception |
| January/February
2003 |
| • |
Transplant
Physician Becomes Senate Majority Leader |
| • |
Public
Policy Committee Updates Advocacy Tools for 108th Congress |
| • |
Senators
DeWine and Durbin Introduce First Transplant Bills of
the 108th Congress |
|
| December
1999 |
| • |
Dr.
William Harmon's Testimony before the Secretary of Health
and Human Services, the Honorable Donna Shalala |
|
|
AST
Makes Progress During the 1st Session of the 109th Congress
and Prepares for 2006
The U.S. Senate and House of Representatives will
soon return to Capitol Hill following a month-long
recess for the holidays. Upon their return to Washington,
D.C., the House and Senate will begin the second year
of this Congress. During this past year, AST was able
to significantly raise the visibility and advance
many of the public policy issues important to the
society’s membership.
AST “raised the bar” once again in 2005
by defining and representing solid organ transplantation
on Capitol Hill and within the Administration. Despite
a very difficult political environment, AST continued
to be called upon by Congressional leaders to:
- Provide expert testimony before the House Appropriations
Subcommittee on NIH and HHS funding priorities for
2006;
- Host the first Congressional Kidney Caucus briefing
“Transplant 101” with Congressmen Kirk
(R-IL) and McDermott (D-WA) to educate targeted
Capitol Hill staffers;
- Garner (in writing) the support of more than
100 members of the House and Senate to support increased
funding for organ donation initiatives;
- Advance and pass the House “Stem Cell Research
Enhancement Act;”
- Develop a General Accountability Office (GAO)
pediatric transplant coverage study with Senators
Grassley (R-IA), DeWine (R-OH), Baucus (DMT), and
Dodd (D-CT);
- Plan and participate in House and Senate transplantation
briefings for targeted offices on Capitol Hill (both
Senate and House);
- Testify before the National Academy of Sciences/Institutes
of Medicine on organ donation initiatives;
- Work closely with House and Senate champions
to reintroduce and support the Immunosuppressive
Drug Coverage Expansion Act;
- Respond and provide expertise to a variety of
Congressional offices regarding questions about
the field of solid organ transplantation.
There is no question 2005 was a very busy year for
the AST Public Policy Committee. In mid-December the
Public Policy Committee met in Chicago to discuss
and formulate strategies for advancing the society’s
government relations goals in 2006. This productive
exercise included the editing and updating of the
AST Key Messages and Public Policy Statements. The
statements are utilized as educational tools on Capitol
Hill.
The society also utilized the Congressional recess
period in late December and early January to meet
with many Congressional aides and the other transplant
stakeholder organizations to identify opportunities
for strengthening and improving the nation’s
solid organ transplantation system.
|
|
| Congressional
Letter from Congressmen Dave Camp (R-MI) and Ted Strickland
(D-OH) to the U.S. House of Representatives Regarding
H.R. 2051
Below is a joint Congressional letter, or “Dear
Colleague,” sent from Congressmen Dave Camp
(R-MI) and Ted Strickland (D-OH) to all 435 members
of the U.S. House of Representatives. The letter urges
all members of Congress to co-sponsor legislation,
H.R. 2051, the Comprehensive Immunosuppressive Drug
Coverage Act of 2005. The American Society of Transplantation
(AST) has worked closely with Congressmen Camp and
Strickland to garner support and advance this important
legislation. The bill seeks to assist kidney recipients
maintain Medicare coverage for immunosuppressive drugs.
As indicated in the Congressional letter, AST strongly
endorses this initiative.
Click
here for a pdf of the letter.
|
|
| AST
Public Policy Committee Advances Agenda and Mobilizes
Congressional Leaders
On September 14 and 15, 2005, the
American Society of Transplantation’s Public
Policy Committee traveled to Capitol Hill for two
days of meetings with Congressional leaders and political
appointees to further garner support for the society’s
key government relations priorities. The Public Policy
Committee also offered the society’s full support
and resources to assist Congress in responding to
Hurricane Katrina.
During visits to Capitol Hill, the
society’s leadership thanked Senators Chuck
Grassley
(R-IA), Mike DeWine (R-OH), Max Baucus (D-MT), and
Chris Dodd (D-CT) for their official support of a
study request to the U.S. General Accountability Office
(GAO). The supporting senators requested that GAO
examine the Medicare program’s transplant follow-up
coverage for children transitioning to adulthood.
In the past, this transition of care has presented
problems and resulted in transplant failure. Senator
DeWine’s office informed AST that the GAO has
accepted the request and is in the process of conducting
the study. AST identified this need and has been working
closely with the Senate to urge GAO to examine this
important issue.
The AST also personally thanked
Congressman Mark Kirk (R-IL), chairman of the Congressional
Kidney Caucus, for his sponsorship of AST’s
recent Capitol Hill briefing, “Transplant 101.”
Congressman Kirk and the Kidney Caucus partnered with
AST to educate congressional staffers about solid
organ transplantation. The society sponsors such Capitol
Hill educational forums annually.
The society’s primary focus
on Capitol Hill was to further garner support for
funding the Organ Donation and Recovery Improvement
Act (Public Law 108 216). This new organ donor law
was enacted into law but lacked congressional funding
for its implementation. AST and other transplant stakeholder
organizations have been working to secure federal
funding to implement this important initiative.
AST also met with federal decision
makers on the House Ways and Means Committee to discuss
congressional legislation seeking to repeal the current
Medicare physician reimbursement system. The chairwoman
of the Ways and Means Subcommittee on Health, Congresswoman
Nancy Johnson (R-CT), has introduced a bill, H.R.
3617, the “Medicare Value Based Purchasing for
Physicians’ Act of 2005.” This legislation
seeks to implement a pay-for-performance framework
that ties quality measurements to Medicare reimbursement.
The Public Policy Committee also
met with the House Energy and Commerce Committee to
discuss Chairman Barton’s (R-TX) draft legislation
to reauthorize/reorganize the National Institutes
of Health (NIH). The society is examining the draft
bill, and crafting comments and an official response.
On October 18, Dr. Mark Schnitzler
represented AST at the House of Representatives staff
briefing. The AST hosted its own briefing, “Transplant
101” in April. This briefing, titled “Organ
Transplant Issues: Medicare, the Organ, and Patient
Lives,” was a collaborative session with multiple
organization sponsors such as the National Kidney
Foundation, the American Society of Transplant Surgeons,
the United Network for Organ Sharing, the North American
Transplant Coordinators Organization, and Roche.
|
|
|
July
12, 2005 letter to the U.S. General Accountability Office
(GAO)
The
following letter was sent on July 12, 2005, to the
U.S. General Accountability Office (GAO). During the
last year, the AST Public Policy Committee has been
working closely to develop this letter with the offices
of: Senator Charles Grassley (R-IA) - Chairman of
the Senate Finance Committee; Senator Christopher
Dodd (D-MA) - Ranking Minority Member of the Senate
Subcommittee on Children and Families; Senator Max
Baucus (D-MT) - Ranking Minority Member of the Senate
Finance Committee; and Senator Mike DeWine (R-OH)
- Member of the Senate Health, Education, Labor and
Pensions Committee and the Senate Appropriations Subcommittee
on Health and Human Services.
The
joint Senate letter requests that the U.S. GAO examine
the transition of care and coverage issues facing
many vulnerable pediatric Medicare program beneficiaries.
(Click
here for pdf of the letter.)
Back
to Top |
|
| AST
Government Relations Spends Much of the Spring on Capitol
Hill
During
the spring season on Capitol Hill, the AST engaged
in a variety of very succesful government relations
activities. As an example, the society’s Public
Policy Committee implemented key initiatives such
as:
- Conducting
the first ever U.S. House of Representatives’
“Kidney Caucus” educational briefing
(Transplant 101) on Capitol Hill;
-
Testifying before the U.S. House of Representatives’
Committee on Appropriations regarding FY 2006 federal
funding for organ transplantation programs;
-
Working with the transplant community and Capitol
Hill to mobilize significant support in the U.S.
House and Senate to support full funding for the
Organ Donation and Recovery Improvement Law; and
-
Convening a two-day Capitol Hill “Fly In”
for members of the AST Public Policy Committee to
meet with and garner the support of key Congressional
offices responsible for legislation
and regulation impacting the field of solid
organ transplantation.
Back
to Top |
| Dr.
Bumgardner Testifies Before House on Federal Funding
for Transplantation
On
April 14, 2005, Dr. Ginny Bumgardner, member of the
AST Board of Directors and Public Policy Committee,
represented the Transplant Roundtable and presented
oral testimony directly to the Chairman of the House
Appropriations Subcommittee for HHS annual funding,
Congressman Ralph Regula (ROH). The purpose of her
testimony was to explain why critical funds are necessary
to implement the Organ Donation and Recovery Improvement
Law. Dr. Bumgardner was very well received by Chairman
Regula. The Chairman had several follow-up questions
that allowed Dr. Bumgardner to further explain to
the Chairman the cost savings that solid organ transplantation
can provide to the federal government. She
was also able to answer some scientific inquiries
and further explain immunosuppression to the Subcommittee
Chairman. Overall,
Dr. Bumgardner’s testimony was compelling and
successfully engaged the Chairman of the Subcommittee.
Dr. Bumgardner is an Ohio constituent of Chairman,
Regula.
Back
to Top |
| AST
Provides First “Transplant 101” Educational
Briefing on Capitol Hill before the Congressional Kidney
Caucus
AST
on April 22, 2005, provided the first educational
briefing before the Congressional Kidney Caucus at
the Rayburn House Office Building as part of the 109th
Session of the U.S. Congress. The briefing included
remarks by Congressman Mark Kirk (R-IL), chair of
the Congressional Kidney Caucus, and information on
topics such as kidney transplantation and the cost
of dialysis.
“Introduction
to Kidney Transplantation” was a 10-minute presentation
given by David Cohen, M.D., the Medical Director for
Kidney Transplant at Columbia University Medical Center,
New York, N.Y.
Mark
Shnitzler, Ph.D., Director of Transplant Outcomes
and Policy Research, and Associate Professor, Internal
Medicine and Community Health, at St. Louis University,
St. Louis, presented “Cost of Dialysis vs. Transplantation
and the Overall Economic Impact.”
“Receiving
a Kidney Transplant” was presented by Barbara
Murphy, M.D., Chief of Kidney/Renal Division, Mt.
Sinai Medical Center, New York, N.Y. “The Patient
Impact of Kidney Immunosuppression Medications”
was presented by Roy First, M.D., Senior Director
of Medical Affairs in Research and Development, Astellas
Pharma U.S. Inc., Deerfield, Ill.
The
briefing presentations were followed by a 20-minute
question and answer session.
Back
to Top |
| AST
Public Policy Committee Fly in to Brief Members of Congress
and Advocate Full Funding of New Organ Donation Law
On
April 18 and 19, 2005, the AST Public Policy Committee
flew more than a dozen of its members to Washington,
DC, for meetings with targeted members of Congress
regarding the importance of providing funding to implement
the Organ Donation and Recovery Improvement Act. The
AST committee was successful in garnering significant
support for federal funds to support this Act in FY
2006. The society also met with a variety of offices
to discuss expanding coverage for immunosuppressive
drugs and the current debate regarding stem cell research.
Back
to Top |
|
| AST
Welcomes New Congress to Capitol Hill
As
the 109th Session of Congress officially convened
in January 2005, the American Society of Transplantation
(AST) was already working to educate newly elected
members of Congress and welcome back many of those
Congressional leaders that have been active champions
on key issues of concern to AST and the field of solid
organ transplantation in the past. In early February
2005, the AST Washington office, located a block from
the White House on Pennsylvania Avenue, delivered
a copy of the Society’s “Position Statements
and Key Messages” into the hands of every Congressional
health care staff member in the U.S. House of Representatives
and U.S. Senate. These policy statements have proven
to be an invaluable resource and tool for communicating
issues and educating federal decision makers regarding
public policy issues impacting the field of transplantation.
Additionally,
the Society’s government relations team also
met with many of the Congressional leaders that have
jurisdiction over federal organ transplantation policies,
including:
- Senate
Majority Leader Bill Frist (R-TN);
-
Speaker of the House of Represenatives Dennis Hastert
(R-IL);
-
Senator Ted Kennedy (D-MA), Ranking Minority Member
of the Senate Committee on Health, Education, Labor
and Pensions (HELP);
-
Congressman Mark Kirk (R- IL), Co-chair of the Congressional
Kidney Caucus;
- Congressman
Mel Watt (D-NC), Chairman of the Congressional Black
Caucus;
- Congressman
Michael Bilirakis (R-FL), Chairman of the House
Energy and Commerce Subcommittee on Health;
-
Congressman Mike Castle (R-DE), Co-chair of the
Congressional Diabetes Caucus;
-
Senator Mike DeWine (R-OH), Member of the Senate
Appropriations Committee and the HELP Committee;
-
Senator Arlen Specter (R-PA), Chairman of the Senate
Appropriations Subcommittee on Health and Human
Services;
-
Senator Richard Durbin (D-IL), Newly elected Senate
Democratic Minority Whip;
-
Senator Chris Dodd (D-CT), Ranking Minority Member
of the Senate HELP Subcommittee on Children.
The
AST also met with newly elected members of Congress,
including Senator Barack Obama (D-IL), a new member
of the U.S. Senate that has a particular interest
in health care and pediatric insurance.
The
beginning of a new Congress also means the reorganization
of some of the Congressional leadership positions.
AST has already begun to meet with the office of the
new chairman of the Senate Committee on Health, Education,
Labor, and Pensions (HELP), Senator Mike Enzi (R-WY).
Enzi replaces Senator Judd Gregg (R-NH) as the new
HELP Committee chairman.
In
addition, the Society has also been working with the
new Chairman of the House Energy and Commerce Committee,
Congressman Joe Barton (R-TX).
Back
to Top |
| Public
Policy Committee Flies into Capitol Hill
On
April 18 and 19, 2005, the AST flew in a dozen members
of the Society’s Public Policy Committee to
meet with the health care leadership of the new Congress
as well as the new Secretary of the Department of
Health and Human Services (HHS), Mike Leavitt. The
Society’s Public Policy team met with more than
a dozen members of Congress, HHS, CMS, and HRSA to
discuss pending legislation and regulation before
these federal decision makers. Some of the issues
discussed by AST on Capitol Hill and within the Administration
included:
-
Pending regulation from the Centers for Medicare
& Medicaid Services (CMS) regarding conditions
of participation (COPs) for transplant centers;
-
Recently introduced legislation by Senators DeWine
(R-OH) and Durbin (D-IL), the “Immunosuppressive
Drug Coverage Expansion Act;”
-
Federal funding to implement the new organ donor
law, the “Organ Donation and Recovery Improvement
Act of 2004;”
-
Health disparities and minority affairs in the field
of solid organ transplantation; and
-
Pediatric insurance and coverage for immunosuppressive
drugs.
The
AST has also been working to develop Congressional
staff briefings on Capitol Hill to present “Transplant
Public Policy 101” briefings for targeted Capitol
Hill staff, including the Congressional Kidney Caucus.
Back
to Top |
| AST
Works with Key National Transplant Stakeholder Organizations
to Fund Organ Donor Law
In
April 2004, President Bush signed the “Organ
Donation and Recovery Improvement Act” into
law. As you know, AST had worked closely with Congress
and HHS for more than four years to garner support
and pass this important legislation into law. The
bill authorized $25 million in new spending for organ
donation related programs to be implemented by the
HHS’ Health Resources and Services Agency (HRSA)
Division on Transplantation (DOT). Unfortunately,
the new law was signed after the federal funding cycle
for FY 2005 was completed. As a result, the new organ
donor law was not provided with adequate funds to
implement many of the new policies, such as providing
resources to support the travel and subsistence costs
for living donors. The new law would have provided
$25 million in new federal dollars to implement programs
and studies to further advance the field of solid
organ transplantation.
Since
this law was not provided with adequate funds to implement
many of the new programs, the AST has been working
closely with the “Transplant Roundtable,”
an informal group of the nation’s transplant
stakeholder organizations, to collectively communicate
our organization’s concerns that funding needs
to be provided for the “Organ Donation and Recovery
Improvement Act.” AST has been working collectively
with the Transplant Roundtable to meet with and educate
every member of the U.S. House and Senate that originally
supported the “Organ Donation and Recovery Improvement
Act” in this past session of Congress, with
a special emphasis on those members of Congress that
supported the bill and also serve on the Appropriations
Committees necessary to fund the new law. The goal
is to have Congress appropriate $25 million in the
FY 2006 federal budget to implement the new organ
donor law. AST has been working in coalition with
11 organizations to secure this goal, including:
-
American Association for the Study of Liver Diseases;
-
American Association of Kidney Patients; American
Association of Tissue Banks;
- American
Liver Foundation;
-
American Society of Pediatric Nephrology;
-
American Society of Transplant Surgeons;
- Association
of Organ Procurement Organizations;
-
Eye Bank Association of America;
-
National Kidney Foundation; and the
-
North American Transplant Coordinators Organization.
Back
to Top |
| New
Secretary Takes Helm at Department of Health and Human
Services (HHS)
After
four years of heading the largest civilian department
in the federal government, Secretary Tommy Thompson
stepped down as the chief executive of the Department
of Health and Human Services (HHS). Thompson’s
leadership and initiatives on issue areas such as
organ donation provided positive visibility and progress
for the field of solid organ transplantation.
On
January 26, 2005, Michael O. Leavitt was sworn in
as the 20th secretary of the HHS department. Leavitt
will manage more than 66,000 employees and a budget
that accounts for almost one out of every four federal
dollars. Prior to his current service, Leavitt served
as administrator of the U.S. Environmental Protection
Agency and governor of Utah. Leavitt served three
terms as the governor of Utah and was the nation’s
longest serving governor. During his eleven years
of service, Utah was recognized six times as one of
America’s best managed States. He has served
as the chairman of the National Governor’s Association,
Western Governors Association, and Republican Governors
Association.
Back
to Top |
|
| AST
Public Policy Committee on Capitol Hill in Preparation
for New Congress
On
December 6 and 7, members of the AST Public Policy
Committee traveled from across the country to meet
in Washington, D.C., in preparation for the opening
of the new 109th Session of Congress, scheduled to
convene in January 2005. The purpose of the strategically-timed
visit to Capitol Hill was to meet with the current
and newly appointed Congressional leaders following
the November national elections. The society’s
Public Policy Committee met with a dozen targeted
Congressional offices and the Department of Health
and Human Services (HHS) to discuss health care public
policy that will likely be addressed by the U.S. House
of Representatives, U.S. Senate, and the White House
in 2005.
During
AST’s time on Capitol Hill, the society met
with a variety of Congressional offices, including
those federal decision-makers that were recently elected
to new leadership positions by their respective parties,
including:
- Congressman
Mel Watt (DNC) — Congressman Watt is the newly
elected chairman of the Congressional Black Caucus.
He replaces outgoing chairman, Congressman Elijah
Cummings (D-MD). AST worked very successfully in
the past with Congressman Cummings to enact federal
law allowing for increased federal employee leave
time to serve as a living donor. The society is
optimistic and excited to work with Congressman
Watt on similar health care public policy issues,
particularly in the area of health care disparities;
-
Senator Richard Durbin (DIL) — Senator Durbin
was elected to serve as the new Senate Minority
Whip, the second highest-ranking Democratic leadership
position in the U.S. Senate. Senator Durbin’s
office had specifically requested a meeting with
the AST Public Policy Committee to discuss the issue
of policies addressing the use of HIVinfected organs.
AST has worked closely and partnered with Senator
Durbin’s office on a variety of organ donation
initiatives in the legislative and regulatory arenas;
and
- Congressman
Mike Castle (R-DE) — Congressman Castle was
selected to serve as the new co-chair of the Congressional
Diabetes Caucus. He will join existing co-chair,
Congresswoman Diana DeGette (D-CO) in leading many
of the diabetes-related initiatives in the new Congress.
In the past, the society has publicly recognized
the leadership of the Diabetes Caucus for their
work in the area of kidney transplantation and pediatric
transplantation issues. The Public Policy Committee
is looking forward to working with Congressman Castle
and continuing its close relationship with Congresswoman
DeGette.
In
addition to meeting with some of the key leaders for
the new 109th Session of Congress, the AST Public
Policy Committee also met with those members of Congress
that have consistently worked as champions with the
society to improve and strengthen the field of solid
organ transplantation, including:
- Senator
Ted Kennedy (DMA) — Ranking Minority Member,
Senate Committee on Health, Education, Labor, and
Pensions (HELP);
-
Senator Bill Frist, M.D. (R-TN) — Majority
Leader of the Senate;
-
Senator Kit Bond (R-MO) — Fourth highest-ranking
member of the Senate Appropriations Committee; and
-
Senator Chris Dodd (D-CT) — Ranking Minority
Member, Senate Subcommittee on Children and Families.
The
society also met with Jim Burdick, M.D., Director
of the Transplant Division of the HHS, Health Resources,
and Services Administration.
Some
of the key issues that AST discussed with federal
decision-makers during the daylong visit to Capitol
Hill included:
-
Pediatric uninsured issues regarding organ transplant
failure when children’s Medicare program coverage
has ended;
-
Minority health care disparities, including progress
and challenges in the field of solid organ transplantation;
and
-
FY 2006 funding for the new Organ Donor and Recovery
Improvement Law.
During
the society’s visits on Capitol Hill, Congressional
aides discussed a variety of policy agenda areas that
may be addressed by the new 109th Congress, including:
-
Medicaid Program Reform Legislation — Many
Congressional leaders have discussed reforming the
program. The newly appointed Secretary of HHS, Mike
Leavitt, is the former Governor of Utah and has
previously been involved with such reform of state
health care programs;
-
Reauthorization of the Children’s Health Act
— This act was last reauthorized in 2000.
At that time, AST worked closely with Congresswoman
DeGette and Majority Leader Frist to include provisions
addressing “The Special Needs of Children
in Transplantation;”
-
Medicare Modernization Act (MMA) technical corrections
legislation — A follow-up bill to include
various amendments to the new Medicare prescription
drug law;
-
Reauthorization of the National Institutes of Health
(NIH) — If addressed by Congress, such a reauthorization
would include a review and overhaul of many programmatic
aspects of the NIH operations; and
-
The annual “must-pass” federal appropriations/
funding for the operations of the Department of
Health and Human Services (HHS), to include NIH,
CMS, CDC, HRSA, etc.
Each
year the society’s leadership and members of
the Public Policy Committee dedicate significant time
and resources to educating, cultivating, and building
relationships with those Congressional and Executive
Branch entities that have oversight and jurisdiction
governing the science and medicine impacting the gift-of-life.
Back
to Top
HHS
Secretary Tommy Thompson Resigns, President Bush Nominates
Former Governor of Utah
On
December 3, 2004, Thompson resigned, following four
years as the nation’s chief health care executive.
Secretary Thompson was a passionate supporter of organ
donation initiatives and personally led a variety
of Administration supported programs seeking to increase
donation and streamline the nation’s system
for solid organ transplantation. AST partnered with
Secretary Thompson on many of his transplantation
initiatives, including national organ donor leave
programs in the private sector and assisting in garnering
national media attention for the Secretary’s
regional transplant collaborative meetings across
the country. Secretary Thompson served as the keynote
speaker during the American Transplant Congress (ATC)
and was awarded the “AST Leadership in Transplantation
Public Policy Award” during the society’s
Capitol Hill Congressional leader reception in 2002.
On
December 13, 2004, President Bush nominated Mike Leavitt
to replace Thompson as Secretary of HHS. Leavitt is
the current Administrator of the Environmental Protection
Agency (EPA) and a former three-term Governor of Utah.
During a press conference at the White House, President
Bush stated that Leavitt was an “ideal choice
to lead one of the largest departments of the United
States Government.” Leavitt praised Bush and
said he “looks forward to the implementation
of the Medicare prescription drug program in 2006,
medical liability reform and finding ways to reduce
the cost of health care.” Similar to Tommy Thompson’s
background, Mike Leavitt was a multi-term Governor
and former chair of the National Governor’s
Association. Leavitt will be taking over an agency
with a $500 billion budget and 67,000 employees.
Back
to Top
|
| National
Elections Change Political Landscape: Transplantation
Champion Elected to Senate Leadership Post
On
November 2, 2004, President Bush was re-elected to
serve four more years in the White House. In addition
to the President’s new mandate, Republicans
also gained seats in the U.S. House of Representatives
and U.S. Senate. Based on the November elections,
the new 109th Session of Congress (scheduled to convene
in January 2005) will be comprised of 55 Republicans,
44 Democrats and 1 Independent in the Senate and 231
Republicans, 202 Democrats and 1 Independent in the
House of Representatives.
Although
some Congressional leadership changes will occur as
a result of the elections, most House and Senate leaders
will remain in their current posts. One of the biggest
surprises of the national elections was the defeat
of the Senate Democratic Leader, Tom Daschle (D-SD),
by former Congressman John Thune (R-SD). Daschle is
the first Senate leader to be defeated since 1952.
With the fall of Senator Daschle, Democrats elected
Senator Harry Reid (D-NV) as the new Democratic Leader.
In addition to Senator Reid, the Democrats also elected
Senator Richard Durbin (D-IL) as the new Minority
Whip, the Senate’s second highest Democratic
leadership position. Durbin, serving his second six
year term as the senior senator from Illinois, has
been a very vocal and active champion for solid organ
transplantation public policy. In 2000, the AST worked
closely with Senator Durbin, the Department of Health
and Human Services, and the widow of former Chicago
Bears football player Walter Payton to develop a national
public service announcement on the importance of organ
donation. In addition, Senator Durbin has introduced
and sponsored several bills seeking to improve immunosuppressive
drug coverage by the Centers for Medicare and Medicaid
Services.
In
addition to Senator Durbin’s elevation to the
No. 2 Democratic post, other key leaders and advocates
for organ transplantation and donation remain intact,
including Senate Majority Leader Bill Frist, M.D.
(R-TN). With the passage and enactment of the Majority
Leader’s “Organ Donation and Recovery
Improvement Act” during this last session of
Congress, the AST will be working with Frist and Durbin
in the new 109th Session of Congress to fully fund
and implement this new law.
Other
key changes that may occur in the new year include
the possibility that the Secretary of the Department
of Health and Human Services (DHHS), Tommy Thompson,
may leave the Department after serving more than four
years as the nation’s top healthcare official.
Thompson and his officials focused significant attention
on transplant and donation public policy issues, including
regional collaborative meetings, the Advisory Committee
on Organ Transplantation (ACOT), and the Workplace
Partnership Initiative. Secretary Thompson also attended
and addressed several meetings of the American Transplant
Congress (ATC). If Thompson decides to depart DHHS,
several names have been mentioned as possible replacements,
including Mark McClellan, who currently heads the
Centers for Medicare and Medicaid Services (CMS).
Back
to Top |
| Educating,
Cultivating, and Mobilizing Congressional Support During
the Summer Months
As the nation prepares for the November
elections and the 108th Session of Congress comes
to a close, the AST Public Policy Committee continued
to raise its significant visibility and educational
efforts on Capitol Hill. On August 12 and 13, 2004,
a dozen members of the society’s Public Policy
Committee traveled to the nation’s capitol for
meetings with key targeted offices, including:
- Secretary of the Department of
Health and Human Services, Tommy Thompson;
- United States Senate Majority Leader,
Bill Frist (RTN);
- Director of the Transplantation
Division, Health Resources, and Services Administration,
Dr. James Burdick;
- Congresswoman Diana DeGette (D-CO),
Chair of the Congressional Diabetes Caucus; and
- Congressman Ruben Hinojosa (D-TX),
Co-Chair of the Congressional Hispanic Caucus.
In addition to the efforts of the
AST Public Policy Committee, the Chair of the society’s
advocacy arm, Dr. Jeff Crippin, traveled again to
Capitol Hill on September 22, 2004, to meet with:
- Senator Kit Bond (R-MO), Chair
of the Senate Aging Subcommittee and Full Appropriations
Committee (jurisdiction over federal funding for
HHS and NIH);
- Congressman Kenny Hulshof (R-MO),
active member of the House Ways and Means Committee
(jurisdiction over Medicare and Medicaid programs);
and
- Congressman Sherrod Brown (D-OH),
Ranking Minority Member of the House Energy and
Commerce Subcommittee on Health (jurisdiction over
Medicare and Medicaid programs).
The primary issues of focus for the
AST’s summer advocacy campaigns included:
- Pediatric insurance coverage for
immunosuppresive medications;
- Minority health care-related issues
in transplantation;
- Funding for the National Institutes
of Health; and Full funding of the “Organ
Donation and Recovery Improvement Act.”
In addition to these recent efforts,
AST’s President, Dr. Jay Fishman, was also on
Capitol Hill earlier in the summer participating in
the Senate Republican Conference’s Minority Healthcare
Quality Forum with the Senate Majority Leader, Director
of the Agency for Healthcare Quality and Research, Director
of the CDC, Deputy Secretary of HHS, and the Director
of the NIH Center for Minority Health Affairs. The society
also joined other national transplant stakeholder organizations
earlier this summer to sponsor two briefings on organ
transplantation for targeted health care officials in
the United States House of Representatives and the United
States Senate. The AST Public Policy Committee also
took time over the summer to review its goals and strategies
for the 109th Congress, scheduled to convene in January
2005. |
| Disparities
in Health Care - AST Meets with Congressional Leaders
and Administration Officials to Address Critical Problems
On
July 7th, 2004, AST's President, Dr. Jay Fishman,
Public Policy Committee Chairman, Dr. Jeffrey Crippin,
and Diversity and Minority Affairs Committee, Dr.
Robert Higgins, joined Congressional leaders and Department
of Health and Human Services decision-makers in the
Library of Congress for the Minority Health Quality
Forum. The purpose of the meeting was to bring together
key stakeholders for a discussion and examination
of the challenges and possible solutions to address
the current gap in our nation's health care system.
AST leaders were able to discuss a variety of health
care disparity challenges with Senate Majority Leader
Bill Frist (R-TN), HHS Deputy Secretary, Claude Allen,
NIH Minority Health Center Director, Dr. John Ruffin,
and HHSAgency for Healthcare Research and Quality
(AHRQ) Director, Dr. Carolyn Clancy.
In
January of 2004, Senate leaders approached AST regarding
the endorsement of S. 2091, the “Closing the
Health Care Gap Act of 2004.” AST provided input
into the crafting of S. 2091 and was one of the original
organizations to endorse the legislation. The bill
seeks to:
• Expand access to quality health for disparity
populations, including through patient navigator systems,
improved linguistic access, health literacy and prevention
efforts, outreach, and expanded access to coverage;
• Strengthen national coordination to reduce
and eliminate disparities;
• Increase the diversity of health professionals
and promote cultural competence research and education;
and
• Expand research to identify sources of health
disparities and to assess intervention strategies.
On
July 26th, 2004, AST’s Public Policy Chair,
Dr. Jeff Crippin, and Immediate Past President, Dr.
Michael Lucey, met with the Director of the HHSAgency
for Healthcare Research and Quality (AHRQ), Dr. Carolyn
Clancy, to further discuss AHRQ’s research in
the area of minority healthcare and disparities. AST’s
leadership, Public Policy Committee, and Diversity
and Minority Affairs Committee, will continue to work
closely with Congress and HHS to address these important
issues.
Back
to Top
|
| Access
to Transplantation - AST Responds to New Inquiries
In
response to increased inquiries from Capitol Hill
and the Administration, AST crafted the following
statement regarding the issue of access to transplantation:
“Transplantation
is an accepted therapy for patients with complications
of organ failure and dysfunction. The American Society
of Transplantation (AST) enthusiastically supports
equal access to transplantation for all patients with
organ failure and/or dysfunction. While recognizing
that selection for transplantation is the prerogative
of the transplant centers, the AST is opposed to restricting
access solely on the basis of race, gender, sexual
orientation, age, disability or the ability to pay.
The AST strongly supports federal and state programs
improving access to transplants, including expansion
of Medicare benefits to patients with organ failure,
similar to the End Stage Renal Disease program for
patients with kidney failure.”
The
AST has added this statement to its portfolio of public
policy “Position Statements & Key Messages.”
These statements are used to further educate and inform
targeted leaders and staff in Congress and the Administration
regarding the field of solid organ transplantation.
The society’s issue papers address many of the
most commonly asked questions by federal decision-makers.
The AST’s Position Statements & Key Messages
may be viewed on the society’s website www.a-s-t.org.
Back
to Top
|
HHS
Re-examines the Issue of Obesity - AST Continues to
Support Key Initiatives to Combat Obesity
On
July 16, 2004, HHS Secretary Tommy Thompson announced
that the Medicare Program will consider reimbursement
for items and services that will improve the health
outcomes of obese beneficiaries. In a change of previous
policy, the Medicare program will begin to decide
on a “case-by-case basis” whether obesity
should be considered a disease for coverage purposes.
Secretary Thompson indicated that language stating
obesity is not an illness has been removed from the
Medicare Coverage Issues Manual, thus paving the way
for possible coverage of anti-obesity procedures.
Based on this new policy, the Centers for Medicare
and Medicaid Services (CMS) has announced that individuals
seeking modification are now encouraged to request
national coverage determinations on specific treatments.
According to HHS, this could include coverage of surgery,
and diet and exercise counseling. During the unveiling
of this new policy, HHS Secretary Thompson stated,
“Medicare will be able to review scientific
evidence in order to determine which interventions
improve health outcomes for seniors and disabled Americans
who are obese and its many associated medical conditions.”
AST
has strongly supported and worked closely with Congressional
leaders on a variety of legislative proposals to address
the growing epidemic of obesity in America, including
the “Improved Nutrition and Physical Activity
Act (IMPACT),” introduced by Senators Frist
(R-TN), Dodd (D-CT) and Bingaman (D-NM), as well as
House Members Mary Bono (R-CA) and Kay Granger (R-TX).
The Senate version of the IMPACT legislation was passed
and approved in late 2003. The Society was specifically
cited and thanked on the Senate floor for its support
and work in moving the legislation forward. The House
IMPACT bill still awaits final action. In addition
to legislative efforts, AST has worked directly with
the HHS Office of the Secretary to bring greater visibility
to this very important issue area.
Back
to Top |
AST
Seeks Full Funding for New Organ Donation and Recovery
Improvement Law
On
April 4, 2004, President Bush signed into law, The
Organ Donation and Recovery Improvement Act. This
legislation has been the number one public policy
agenda item for the Society during the last two sessions
of Congress. AST first addressed this initiative in
1999, when the public policy committee worked with
Senators Kennedy (D-MA) and Frist (R-TN) to craft
bipartisan legislation to reauthorize key elements
of the National Organ Transplant Act. Despite a variety
of road blocks, AST was able to work with House and
Senate leaders, as well as other transplant stakeholders/organizations
to garner enough support to finally get this important
legislation to the President's desk. The bill seeks
to provide new resources to increase donation, including
providing reimbursement of the travel and subsistence
costs associated with living donation, providing greater
resources to states to expand their public education
and outreach effort, and awarding grants to coordinate
organ donation activities of eligible hospitals and
organ procurement organizations.
Now that the law has been enacted, the Society has
focused significant efforts on securing funding from
Congress to implement the various programs, policies
and new authorizations contained in the Act. The Organ
Donation and Recovery Improvement Act authorizes $25
million in new funding. If fully appropriated by Congress,
the new law would be able to provide: 1) $23 million
for the Health Resources and Services Administration's
(HRSA) Division of Transplantation (DOT) to promote
organ donation education and awareness, provide grants
for travel and living expense reimbursement for living
donors, and grants for hospital organ coordinators;
and 2)$2 million for the Agency for Health Care Research
and Quality (AHRQ) to study and develop scientific
evidence in support of efforts to increase organ donation
and improve the recovery, preservation, and transportation
of organs.
Back
to Top |
AST
Convenes First-Ever National Conference on the "Economics
of Transplantation"
On
April 16th, the AST sponsored the first ever national
conference on the Economics of Transplantation. This
conference brought together experts from the fields
of transplantation, economics, industry and government,
in order to present and discuss the economic issues
of solid organ transplantation. The meeting included
guest speakers such as Craig Burton, the Department
of Health and Human Services' Deputy Assistant Secretary
for Legislation.
Burton
joins a long list of distinguished guest speakers,
including HHS Secretary Tommy Thompson, Senate Majority
Leader Bill Frist (R-TN) and Dr. Anthony Fauci, director,
NIH-NIAID, who have addressed national AST policy
forums.
The Deputy Assistant Secretary provided an overview
of the Department’s initiatives in the area
of national organ donation public policy, which the
Department strongly supports by raising visibility
of organ donation, giving the gift-of-life and increasing
the number of available organs.
Back
to Top
|
AST
Attends Senate Republican Conference's Minority Health
Quality Forum
On
June 7, 2004, AST public policy Chair, Dr. Jeffrey
Crippin, and the Society's Director of Government
Relations, William Applegate, joined Senate Majority
Leader Bill Frist (R-TN), Senator Rick Santorum (R-PA)
and other key Republican leaders in the US Senate
to establish a dialogue among leading medical associations,
public hospitals, community health centers, and outreach
organizations about the disparities that exist for
minority ethnic groups.
The
meeting included most of the Republican Chairs and
active health care champions serving on Senate Committees
with jurisdiction over health care related issues.
Specific focus areas addressed during the meeting
included:
• Minority health care quality;
• Minority health research;
• Preventive care;
• Chronic care models;
• Cultural fluency; and
• Patient navigators.
Key
presenters and speakers included Claude Allen, deputy
Secretary of HHS, Dr. Carolyn Clancy, Director of
the Agency for Health Care Research and Quality (AHRQ),
Dr. John Ruffin, NIH National Center on Minority Health
and Health Disparities, and Dr. Julie Gerberding,
director of the Centers for Disease Control.
Earlier this year, AST worked closely with Senate
Majority Leader Frist to develop and support the "Closing
the Health Care Gap Act of 2004."
Back
to Top
|
Society
Provides Expertise to the Office of the HHS Secretary
and Broader Department Officials on Issue of Generic
Drugs and Immunosuppression
At
the request of the Office of the Secretary of the
Department of Health and Human Services (HHS), AST's
Past President and former Chair of the Society's public
policy committee, Dr. William Harmon, traveled to
the HHS headquarters in Washington, DC, on March 5,
2004, to meet with a variety of key HHS Department
officials on the issue of generic drugs and immunosuppression.
AST was asked by the General Counsel of HHS to provide
the Department with an overview of the AST's findings
from its past Consensus Conference on generic drugs
and the Society's white paper that was developed following
the conference.
The
HHS meeting included key political appointees and
officials from the:
• Office of the Secretary of HHS;
• Centers for Medicare and Medicaid Services;
• Health Resources and Services Administration;
• Food and Drug Administration;
• HHS Assistant Secretary for Planning and Evaluation;
and
• National Institutes of Health - NIAID.
Back
to Top |
Public
Policy Committee Meets on Capitol Hill to Kick-Off the
Second Session of the 108th Congress
On
February 23 & 24, 2004, the AST public policy
committee met in Washington, DC to kick-off the Second
Session of the 108th Congress. More than a dozen members
of the Society's public policy committee traveled
to the nation's capitol to meet with key Congressional
leaders and other transplantation stakeholder organizations.
Given that the Congress had just reconvened to finish
the second half of this legislative session, the Society
felt it was very important to meet with and coordinate
government relations efforts with other stakeholder
organization's that share many of the same pubic policy
goals as AST. These outreach meetings included discussions
with the Association of Organ Procurement Organizations
(AOPO), National Kidney Foundation (NKF), and the
Texas Transplantation Society (TTS).
In
addition to strategy meetings with the organ transplantation
community, the public policy committee hosted a luncheon
discussion with the Legislative Director to Congressman
Jay Inslee (WA), sponsor of organ donor coordinator
legislation, and the Senior Health Policy Aide to
Congresswoman Diana DeGette (CO), Co-Chair of the
Congressional Diabetes Caucus and a very active member
of the House Energy and Commerce Subcommittee on Health.
Back
to Top
|
AST
Works with Congressional Leaders to Introduce Health
Disparity Legislation - "Closing the Health Care
Gap Act"
During
the first months of the new year, AST was approached
by a bi-partisan team of Congressional leaders to
assist in reviewing a legislative proposal to address
health disparity issues. The Society worked with the
offices of Senate Majority Leader Bill Frist (R-TN)
and Senator Mary Landrieu (D-LA) to support the introduction
of the, "Closing the Health Care Gap Act."
The legislation was introduced on February 12, 2004.
The Society was one of the very first organizations
to endorse the legislation.
This
important bill seeks to reduce and eliminate health
disparities for racial and ethnic minorities and other
| | | |